In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Call for less regulation in German healthcare sector

This article was originally published in Clinica

Executive Summary

Germany's industry federation, the BDI, has urged that market forces be allowed to have due influence over the national healthcare products sector. Speaking at the annual general meeting of medtech industry association Spectaris, in Stuttgart last week, BDI deputy-president Friedhelm Loh said: "German can only be a worldwide leader in healthcare innovations when there is free pricing that promotes competition for such innovative products." He added that only then will it be possible for companies to invest in relatively costly and high-risk products.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts